Loading…
Disease-modifying therapies in multiple sclerosis in Latin America
The treatment of multiple sclerosis (MS) has become increasingly complex during the last 10 years, mainly because of the advent of new and more potent disease-modifying therapies (DMTs). In Latin America, the therapeutic repertoire available for MS treatment is similar to the one in the rest of the...
Main Authors: | Skromne-Eisenberg, Eli, Ordoñez-Boschetti, Laura, Treviño-Frenk, Irene |
---|---|
Format: | Online Article Text |
Language: | English |
Published: |
SAGE Publications
2017
|
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617092/ https://www.ncbi.nlm.nih.gov/pubmed/28979794 http://dx.doi.org/10.1177/2055217317723369 |
Similar Items
-
The genetics of multiple sclerosis in Latin America
by: Rivas Alonso, Verónica, et al.
Published: (2017) -
Multiple sclerosis epidemiology in Latin America: An updated survey
by: Cristiano, Edgardo, et al.
Published: (2017) -
Differential diagnosis of multiple sclerosis in Latin America
by: Fragoso, YD, et al.
Published: (2017) -
The challenges and opportunities of multiple sclerosis care in Latin America
by: Ontaneda, Daniel, et al.
Published: (2017) -
Application of the McDonald criteria in Latin America
by: Patrucco, Liliana
Published: (2017)